Plunkett Research Online: Dendreon Pharmaceuticals LLC

DENDREON PHARMACEUTICALS LLC (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Dendreon Pharmaceuticals, LLC discovers, develops and commercializes active cellular immunotherapy and small molecule product candidates to treat a wide range of cancers. The company’s FDA-approved product is Provenge (sipuleucel-T), an autologous cellular immunotherapy for the treatment of asympto.....


DENDREON PHARMACEUTICALS LLC

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 877-256-4545
Fax:
Address: 1700 Saturn Way
Seal Beach, CA 90740 United States

Types Of Business
Industry Ranks

Industry NAICS code:
Parent Company: Nanjing Xinjiekou Department Store Co Ltd

ContactsDescription

Jason O'NeillCEO
Andrew SandlerChief Medical Officer/Executive VP
See More
Dendreon Pharmaceuticals, LLC discovers, develops and commercializes active cellular immunotherapy and small molecule product candidates to treat a wide range of cancers. The company’s FDA-approved product is Provenge (sipuleucel-T), an autologous cellular immunotherapy for the treatment of asympto.....See More See More

$USD, In whole numbers 2019201820172016201520142013
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture